Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Can-Fite to initiate Phase I/II liver cancer trial
Can-Fite, an Israeli biotechnology company, has reported that, following the approval by the Israel Ministry of Health and Rabin MC Ethics Committee, a Phase I/II clinical trial with
Can-Fite, an Israeli biotechnology company, has reported that, following the approval by the Israel Ministry of Health and Rabin MC Ethics Committee, a Phase I/II clinical trial with
Intuitive Surgical, a developer and marketer of robotic technologies, has reported a net income of $28.14m, or $0.72 per diluted share, for the first quarter of 2009, compared
Sud-Chemie, a specialty chemicals company headquartered in Munich, Germany signed an agreement with BASF to acquire BASF’s production site for synthesis gas (syngas) catalysts at Nanjing, China. The
Adeona Pharmaceuticals, a specialty pharmaceutical company, has entered into an agreement to acquire Colwell Clinical Laboratories, a CLIA-certified clinical laboratory and a licensed Medicare and MediCal provider. Adeona
Additionally, data assessing fibroblast growth factor receptor-2 (FGFR-2) response to an FGFR antagonist in a novel FGFR-2 driven model were also presented. According to Aveo, preclinical data demonstrated
“We must hasten our progress against cancer by conducting exciting new science, which this year’s increase in funding, in addition to anticipated funds from the American Recovery and
The Agilent SureSelect Target Enrichment system, optimized for Illumina’s widely-adopted next-generation sequencing platform, the Genome Analyzer, provides researchers with a method for efficiently resequencing specific regions of interest
Ms Langouet has degrees in computer science and physiology. Since graduation her career has been in data management, programming, data systems and validation, process and change management, compliance
The combination of Hadasit’s oral immune modulation with Immuron’s existing oral protein and antibody technology could yield a convenient, all-natural, side-effect-free approach to address serious diseases including metabolic
“It is a pleasure for me to join the expert management and extended scientific team of Combimatrix Molecular Diagnostics. Array CGH testing has been the latest methodology to